Immune drug-induced hemolytic anemias.
D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000276:immunology; D000906:Antibodies; D000936:Antigen-Antibody Complex; D000941:Antigens; D001323:Autoantibodies / Q000378:metabolism; D001327:Autoimmune Diseases / Q000139:chemically induced; D002511:Cephalosporins / Q000009:adverse effects / Q000276:immunology; D002746:Chlorpromazine / Q000009:adverse effects; D003298:Coombs Test; D004342:Drug Hypersensitivity; D004912:Erythrocytes / Q000276:immunology; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D008214:Lymphocytes / Q000276:immunology; D008528:Mefenamic Acid / Q000009:adverse effects; D008750:Methyldopa / Q000009:adverse effects; D008784:Methysergide / Q000009:adverse effects; D010406:Penicillins / Q000276:immunology
D000906:Antibodies; D000936:Antigen-Antibody Complex; D000941:Antigens; D001323:Autoantibodies; D002511:Cephalosporins; D006827:Hydantoins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D010406:Penicillins; D008528:Mefenamic Acid; D008750:Methyldopa; D002746:Chlorpromazine; D008784:Methysergide